Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
News
Overview
Regulatory News
Overview
Regulatory News
Home
UK Shares
UK SHARES
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
MARKET DATA
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
FUNDS
Funds Centre
Managers
News
Brokers
BROKERS
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
SPREAD BET
Learn
Strategies
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist
Sector
Pharma and Biotech
Indices
FTSE 100
FTSE-350
FTSE All-Share
techMARK
GSK (GSK)
1,470.50p
12:40 02/05/25
0.51%
7.50p
Today's Low & High
1,450.00
/
1,473.50
Open / Previous Close
1,450.00 / 1,463.00
52-week range
-14.93%
-258.00p
Volume
1,630,782
Market Cap(million)
£60,433.60m
Advertising
News
Overview
Regulatory News
Latest webfg news
GSK's Nucala delivers positive outcomes in published trial results
01 May
London close: Stocks finish higher as US economy contracts
30 Apr
GSK confirms guidance after strong first quarter
30 Apr
Two GSK vaccines get US CDC recommendations
17 Apr
London close: Stocks fall as China retaliates to latest US tariffs
09 Apr
London close: Stocks slide in global reaction to Trump tariffs
03 Apr
UK pharma stocks avoid selloff
03 Apr
EMA accepts GSK's application to expand Nucala use
24 Mar
FDA to review GSK's depemokimab
03 Mar
London close: Stocks little changed after UK data dump
21 Feb
GSK seen as potential target for activist investors
21 Feb
London close: Stocks slip as US jobless claims rise
20 Feb
GSK 5-in1 meningitis drug gets US approval
17 Feb
London close: Stocks rise as trade tensions continue
05 Feb
GSK ups five-year sales outlook, unveils $2bn buyback
05 Feb
GSK's pre-filled shingles vaccine accepted for review by EMA
27 Jan
EU regulators expand usage of GSK's Jemperli cancer drug
20 Jan
Pfizer pares back Haleon stake in £2.5bn sale
15 Jan
London close: Stocks fall, pound weakens further on rising bond yields
13 Jan
GSK to buy IDRx for up to $1.15bn
13 Jan
«
2025-01
2025-02
2025-03
2025-04
2025-05
Loading:
Login with Facebook
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In